Literature DB >> 9243030

The emerging infections network: a new venture for the Infectious Diseases Society of America. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network.

.   

Abstract

The Infectious Diseases Society of America (IDSA), in cooperation with the Centers for Disease Control and Prevention, has launched an Emerging Infections Network (EIN). This network of infectious diseases consultants was conceived as a sentinel system to monitor new or resurgent infectious diseases in a way that would complement other public health surveillance efforts. A pilot study with 169 participants recruited from 32 of the IDSA's state and regional societies confirmed the feasibility and potential value of this network. More than 300 infectious diseases consultants are currently participating in the IDSA EIN. Future plans include aggressive probing for clinical experiences that indicate or suggest the presence of emerging infections, initiation of prospective studies for selected infectious diseases, and other activities designed both to benefit consultants in infectious diseases and to make use of their services.

Entities:  

Mesh:

Year:  1997        PMID: 9243030

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Diagnostic delays in infectious diseases.

Authors:  Manish Suneja; Susan E Beekmann; Gurpreet Dhaliwal; Aaron C Miller; Philip M Polgreen
Journal:  Diagnosis (Berl)       Date:  2022-01-20

2.  Clinical experience, infection control practices and diagnostic algorithms for poxvirus infections - an Emerging Infections Network survey.

Authors:  Christine M Hughes; Edith R Lederman; Mary G Reynolds; Inger K Damon; R Ryan Lash; Susan E Beekmann; Philip M Polgreen
Journal:  BMC Res Notes       Date:  2010-02-25

3.  Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey.

Authors:  Jonas Marschall; Michael A Lane; Susan E Beekmann; Philip M Polgreen; Hilary M Babcock
Journal:  Int J Antimicrob Agents       Date:  2013-01-09       Impact factor: 5.283

4.  Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians.

Authors:  Michael A Lane; Jonas Marschall; Susan E Beekmann; Philip M Polgreen; Ritu Banerjee; Adam L Hersh; Hilary M Babcock
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05-09       Impact factor: 3.254

5.  Recognition and diagnosis of Cryptococcus gattii infections in the United States.

Authors:  Sally Ann Iverson; Tom Chiller; Susan Beekmann; Philip M Polgreen; Julie Harris
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

6.  Prevalence and Characteristics of Neuroinfectious Disease Inquiries Within the Emerging Infections Network: A 22-Year Retrospective Study.

Authors:  Elizabeth Matthews; Luisa A Diaz-Arias; Susan E Beekmann; Philip Polgreen; Greer Waldrop; Vivian Yang; Kathryn Rimmer; Arun Venkatesan; Kiran T Thakur
Journal:  Open Forum Infect Dis       Date:  2020-05-09       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.